Madison Area Lyme Support Group

The Warburg effect — Otto Warburg’s seminal observation that cancer cells preferentially ferment glucose into lactate even in oxygen-rich conditions — represents a metabolic vulnerability ripe as the perfect therapeutic target for cancer treatment.

Yet, a century after its elucidation, oncology remains tethered to genetic paradigms, sidelining metabolic strategies in favor of cytotoxic and targeted interventions that work at best on about 15% of cancers, representing an abysmal “treatment” model.

Early anecdotal findings of thousands upon thousands of patients show that administering a synergistic combination therapy of repurposed miracle drugs across a large variety of cancers is efficacious in about 80%+ of patients, representing the all-elusive until now ‘holy grail’ cancer cure.

This willful neglect of the cure in plain sight, rooted in Rockefeller Eugenics, allopathic BigPharma, and industrial influences traceable to the early 20th century, has perpetuated a cancer “care” model that prioritizes profit over lives that is designed to relieve patients of the maximum amount of money en route to torturous iatrogenic outcomes, and/or being sent home to die.

Emerging metabolic therapies, including repurposed drugs like Ivermectin (IVM) and Fenbendazole  (FBZ), alongside the rare sugar allulose, challenge this orthodoxy by directly targeting the glycolytic dependency of malignant cells. (Cancer cells are sugar dependent, whereas healthy cells use mostly oxygen to convert to energy stores.)

This highlights the Ivermectin Fenbendazole Allulose revolution sweeping the planet, with recent supply chain strains of IVM and FBZ from India with huge increases in Worldwide demand.

Hundreds of thousands of late stage cancer prognoses are being declared full remission as borders across the world are doing there level best to seize IVM and FBZ on behalf of the corrupt governmental agencies that are bought and paid for by BigPharma and their Deep State partners-in-crime.

We will now explore the mechanisms underlying these agents (Ivermectin, Fenbendazole and Allulose) with Warburg’s insights, and their broader implications for cancer, type 2 diabetes, and obesity—conditions united by metabolic dysregulation.  (See link for article)

_______________

For more:

• https://madisonarealymesupportgroup.com/2025/02/07/cancer-disappeared/
• https://madisonarealymesupportgroup.com/2024/10/23/alternative-cancer-treatments-18-proven-interventions/
• https://madisonarealymesupportgroup.com/2024/10/15/first-cancer-protocol-using-ivermectin-mebendazole-and-fenbendazole-published/
• https://madisonarealymesupportgroup.com/2025/02/20/the-remarkable-anti-cancer-potential-of-mushrooms/
• https://madisonarealymesupportgroup.com/2023/04/14/dr-alan-mcdonald-lyme-links-to-alzheimers-cancer-leukemia-liver-damage-suicide/
• https://madisonarealymesupportgroup.com/2023/05/19/study-starling-connection-between-lyme-blood-cancer/
• https://madisonarealymesupportgroup.com/2023/04/28/growing-connection-between-infections-cancer/